Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Esperion Therapeutics, Inc.”

53 pharma patents match "Esperion Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 53
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 53 pharmaceutical patents matching "Esperion Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

53 results for “Esperion Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 8119590

    Prevention and treatment of restenosis by local administration of drug

    Esperion Therapeutics, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  2. US 8084498

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted
  3. US 8067466

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

    Esperion Therapeutics, Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  4. US 7838554

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  5. US 7812199

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted
  6. US 7709515

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Esperion Therapeutics, Inc. · Granted May 4, 2010 · Expires Apr 29, 2030

    granted
  7. US 7705177

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  8. US 7576130

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted
  9. US 7335689

    Dihydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  10. US 7335799

    Hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted
  11. US 7192940

    Ether compounds

    Esperion Therapeutics, Inc. · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted
  12. US 7119221

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted
  13. US 6953840

    Methods of using non-human animal Apolipoprotein A-I protein

    Esperion Therapeutics, Inc. · Granted Oct 11, 2005 · Expires Oct 6, 2025

    expired
  14. US 6909014

    Intermediates for the synthesis of ether compounds

    Esperion Therapeutics, Inc. · Granted Jun 21, 2005 · Expires Jun 16, 2025

    expired
  15. US 6831105

    Compositions comprising ether compounds and pharmaceutical uses therefor

    Esperion Therapeutics, Inc. · Granted Dec 14, 2004 · Expires Dec 9, 2024

    expired
  16. US 6790953

    Ether compounds

    Esperion Therapeutics, Inc. · Granted Sep 14, 2004 · Expires Sep 9, 2024

    expired
  17. US 6713507

    Ether compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 30, 2004 · Expires Mar 25, 2024

    expired
  18. US 6703422

    Sulfide and disulfide compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 9, 2004 · Expires Mar 4, 2024

    expired
  19. US 6699910

    Ketone compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Mar 2, 2004 · Expires Feb 26, 2024

    expired
  20. US 6673780

    Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired
  21. US 6646170

    Intermediates for the synthesis of ether compounds

    Esperion Therapeutics, Inc. · Granted Nov 11, 2003 · Expires Nov 6, 2023

    expired
  22. US 6617134

    Dimer of molecular variant of apolipoprotein and processes for the production thereof

    Esperion Therapeutics, Inc. · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired
  23. US 6506879

    Purified Apo A and Apo E compounds and methods for using them

    Esperion Therapeutics, Inc. · Granted Jan 14, 2003 · Expires Jan 9, 2023

    expired
  24. US 6506799

    Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds

    Esperion Therapeutics, Inc. · Granted Jan 14, 2003 · Expires Jan 9, 2023

    expired